Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Beauty Health (SKIN) Invested Capital (2020 - 2026)

SkinHealth Systems has reported Invested Capital over the past 6 years, most recently at $185.0 million for Q4 2025.

  • Quarterly Invested Capital rose 257.15% to $185.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $185.0 million through Dec 2025, up 257.15% year-over-year, with the annual reading at $185.0 million for FY2025, 257.15% up from the prior year.
  • Invested Capital was $185.0 million for Q4 2025 at SkinHealth Systems, up from $65.7 million in the prior quarter.
  • Over five years, Invested Capital peaked at $345.4 million in Q2 2022 and troughed at -$142.1 million in Q3 2021.
  • The 5-year median for Invested Capital is $71.6 million (2024), against an average of $115.8 million.
  • Year-over-year, Invested Capital crashed 605620.03% in 2021 and then soared 2049.38% in 2022.
  • A 5-year view of Invested Capital shows it stood at $298.0 million in 2021, then crashed by 43.95% to $167.1 million in 2022, then plummeted by 64.45% to $59.4 million in 2023, then decreased by 12.77% to $51.8 million in 2024, then soared by 257.15% to $185.0 million in 2025.
  • Per Business Quant, the three most recent readings for SKIN's Invested Capital are $185.0 million (Q4 2025), $65.7 million (Q3 2025), and $74.0 million (Q2 2025).